ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 220,000
-3,000 (-1.35%)
Oct 29, 2026, 3:30 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 15.32 trillion as of October 29, 2026. It is the 1,936th most valuable company in the world and the 42nd biggest in South Korea. Its market cap has decreased by 39.83% in one year.
Market Cap
15.32T
Enterprise Value
14.99T
Revenue
254.01B
Global Rank
Country Rank
#42 South Korea
PE Ratio
84.28
ChartMarket Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 15.32T, an increase of 12,669.16%. That is a compound annual growth rate of 50.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 15.32T | -36.28% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.44T |
| Celltrion | 43.36T |
| Samsung Epis Holdings | 7.86T |
| SK Biopharmaceuticals | 5.89T |
| HLB Co., Ltd. | 5.40T |
| SK bioscience | 2.51T |
| LigaChem Biosciences | 2.44T |
| ABL Bio | 2.34T |